Advanced Micro Devices vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 73)

Advanced Micro Devices

LeaderConsumer Technology

Enterprise

Santa Clara semiconductor (NASDAQ: AMD) at $268B market cap; OpenAI 6 GW Instinct GPU partnership ($100B+ over 4 years, Oct 2025), Q3 2025 data center $4.3B revenue competing with NVIDIA for AI accelerator market.

AI VisibilityBeta
Overall Score
B73
Category Rank
#99 of 290
AI Consensus
70%
Trend
stable
Per Platform
ChatGPT
74
Perplexity
67
Gemini
78

About

Advanced Micro Devices, Inc. (AMD) is a Santa Clara, California-based semiconductor company — publicly traded on NASDAQ (NASDAQ: AMD) as an S&P 500 component — designing CPUs, GPUs, FPGAs, and AI accelerators for data centers, gaming, PCs, and embedded systems with approximately 26,000 employees and a market capitalization of approximately $268 billion (June 2024). In Q3 2025, AMD's data center segment revenue reached $4.3 billion, driven by Instinct AI accelerators and EPYC server processors. In October 2025, AMD announced a multibillion-dollar strategic partnership with OpenAI — OpenAI will deploy 6 gigawatts of AMD Instinct GPUs, expected to generate over $100 billion in new revenue for AMD over four years, with OpenAI receiving a warrant for up to 160 million AMD shares (potential ~10% stake). AMD stock surged 23.71% on the announcement. CEO Dr. Lisa Su (since 2014) led one of Silicon Valley's most celebrated turnarounds, growing AMD stock from ~$3 to ~$140+ per share. AMD was founded in 1969 by Jerry Sanders; key acquisitions include ATI Technologies (2006, GPUs) and Xilinx ($49 billion, 2022, FPGAs).

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

73
Overall Score
90
#99
Category Rank
#9
70
AI Consensus
60
stable
Trend
stable
74
ChatGPT
99
67
Perplexity
99
78
Gemini
83
76
Claude
96
68
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.